The potential SARS-CoV-2 entry inhibitor
Jrhau Lung, Yu‐Shih Lin, Yao‐Hsu Yang, Yu‐Lun Chou, Geng‐He Chang, Ming‐Shao Tsai, Cheng‐Ming Hsu, Reming‐Albert Yeh, Li‐Hsin Shu, Yu‐Ching Cheng, Hung Te Liu, Ching‐Yuan Wu
The paper identifies theaflavin as a potential SARS-CoV-2 entry inhibitor by showing its favorable binding to the RBD of the spike protein.
bioRxiv · Mar 26, 2020 · PreprintBioinformatics